<DOC>
	<DOCNO>NCT00354770</DOCNO>
	<brief_summary>This 12-week , double-blind study N-Acetyl Cysteine treatment trichotillomania</brief_summary>
	<brief_title>N-Acetyl Cysteine Trichotillomania</brief_title>
	<detailed_description>The goal propose study evaluate efficacy safety N-Acetyl Cysteine ( NAC ) trichotillomania . Forty subject DSM-IV trichotillomania receive 12 week double-blind NAC placebo . The hypothesis test NAC effective well tolerated patient trichotillomania compare placebo . The propose study provide need data treatment disable disorder currently lack clearly effective treatment .</detailed_description>
	<mesh_term>Trichotillomania</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>men woman age 1865 ; current DSMIV trichotillomania unstable medical illness ; history seizure ; myocardial infarction within 6 month ; current pregnancy lactation , inadequate contraception woman childbearing potential ; thought suicide ; lifetime history DSMIV bipolar disorder type I , dementia , schizophrenia DSMIV psychotic disorder ; previous treatment NAcetyl Cysteine ; treatment investigational medication depot neuroleptic within 3 month , fluoxetine within 6 week , psychotropics within 2 week prior study baseline ; 9 ) diagnosis asthma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Trichotillomania</keyword>
	<keyword>Hair-pulling</keyword>
</DOC>